Mercer Global Advisors
VNDA icon

Mercer Global Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Mercer Global Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Buy
122,546
+56,757
+86% +$371K ﹤0.01% 1975
2026
Q1 		$455K Buy
65,789
+21,960
+50% +$169K ﹤0.01% 2055
2025
Q4 		$387K Buy
43,829
+14,836
+51% +$81.7K ﹤0.01% 2044
2025
Q3 		$145K Buy
+28,993
New +$134K ﹤0.01% 2457

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's VNDA Position: Q2 2026 in Review

Mercer Global Advisors increased its Vanda Pharmaceuticals (VNDA) stake by 86% in Q2 2026, buying an estimated $371K and bringing the position to 122,546 shares worth $750K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Mercer Global Advisors first reported a position in VNDA in Q3 2025 and has held it in 4 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Mercer Global Advisors held 122,546 shares of Vanda Pharmaceuticals worth $750K as of Q2 2026.
  • Mercer Global Advisors bought 56,757 Vanda Pharmaceuticals shares in Q2 2026, an estimated $371K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1975 holding.
  • Mercer Global Advisors first reported a position in Vanda Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.